ArticleFrontiers in microbiology2016
Serotype 3 Remains the Leading Cause of Invasive Pneumococcal Disease in Adults in Portugal (2012-2014) Despite Continued Reductions in Other 13-Valent Conjugate Vaccine Serotypes.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.
0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
47 citing papers in PubMed, 77 citations in OpenAlex.
- Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults.Human vaccines & immunotherapeutics · 2019Trial
- Persistence of vaccine-induced serotype-related pathology in invasive pneumococcal disease in children. Community of Madrid, 2007-2024.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Serotype 3 invasive pneumococcal disease in Tuscany across the eras of conjugate vaccines (2005-2024) and anthropic-driven respiratory virus fluctuations.Human vaccines & immunotherapeutics · 2025Article
- The resilience of vaccine serotypes in adult invasive pneumococcal disease in Portugal, 2018-2023.Scientific reports · 2025Article
- Observational
- Cost-Effectiveness of the Pneumococcal Vaccine in the Adult Population: A Systematic Review.Healthcare (Basel, Switzerland) · 2024Review
- Evolution of invasive pneumococcal disease by serotype 3 in adults: a Spanish three-decade retrospective study.The Lancet regional health. Europe · 2024Article
- Article
- Development of semisynthetic saponin immunostimulants.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2024Review
- Emerging vaccine strategies against the incessant pneumococcal disease.NPJ vaccines · 2023Review
- Systematic Review and Meta-Analysis of the Efficacy and Effectiveness of Pneumococcal Vaccines in Adults.Pathogens (Basel, Switzerland) · 2023Review
- Magnetic bead-based separation of pneumococcal serotypes.Cell reports methods · 2023Article
- Adult non-invasive pneumococcal pneumonia in Portugal is dominated by serotype 3 and non-PCV13 serotypes 3-years after near universal PCV13 use in children.Frontiers in public health · 2023Article
- An Experimental Human Colonization Model with Pneumococcal Serotype 3 has the Potential to be Used for Vaccine Studies.American journal of respiratory and critical care medicine · 2022Article
- Pneumococcal within-host diversity during colonization, transmission and treatment.Nature microbiology · 2022Article
- Membrane particles evoke a serotype-independent cross-protection against pneumococcal infection that is dependent on the conserved lipoproteins MalX and PrsA.Proceedings of the National Academy of Sciences of the United States of America · 2022Article
- Serotype 1 pneumococcus: epidemiology, genomics, and disease mechanisms.Trends in microbiology · 2022Review
- Non-invasive pneumococcal pneumonia due to vaccine serotypes: A systematic review and meta-analysis.EClinicalMedicine · 2022Article
- Potentiating pneumococcal glycoconjugate vaccine PCV13 with saponin adjuvant VSA-1.Frontiers in immunology · 2022Article
- Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13.Microbiology spectrum · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Andreia N HorácioAuthor Affiliations: Centro Hospitalar do Barlavento Algarvio; Hospital de Cascais; Centro Hospitalar de Coimbra; Centro Hospitalar de Entre Douro e Vouga; Centro Hospitalar de Lisboa Central; Centro Hospitalar Lisboa Norte; Centro Hospitalar Lisboa Ocidental; Centro Hospitalar de Vila Nova de Gaia/Espinho; Centro Hospitalar do Alto Ave; Centro Hospitalar do Baixo Alentejo; Centro Hospitalar do Porto; Centro Hospitalar da Póvoa do Varzim/Vila do Conde; Hospital de Vila Real; Hospitais da Universidade de Coimbra; Hospital Central do Funchal; Hospital Curry Cabral, Lisboa; Hospital de Santa Luzia, Elvas; Hospital de Santo André, Leiria; Hospital de São João, Porto; Hospital de Braga; Hospital Dr. José Maria Grande, Portalegre; Hospital do Espírito Santo, Évora; Hospital dos SAMS, Lisboa; Hospital Dr. Fernando da Fonseca, Amadora/Sintra; Hospital Garcia de Orta, Almada; Hospital Infante D. Pedro, Aveiro; Hospital de São Teotónio,Viseu; Hospital Pedro Hispano, Matosinhos; Instituto Nacional de Saúde Ricardo Jorge, Porto; Hospital Reynaldo dos Santos, Vila Franca de Xira; Unidade Local de Saúde do Alto Minho; Hospital CUF Descobertas; Centro Hospitalar do Tâmega e Sousa; Hospital Beatriz Ângelo, Loures; Centro Hospitalar de Setúbal; Hospital Distrital de Santarém; Centro Hospitalar do Médio Ave; Hospital de Faro; Centro Hospitalar do Oeste Norte; Hospital da Luz; Hospital da Figueira da Foz.
Catarina Silva-CostaAuthor Affiliations: Centro Hospitalar do Barlavento Algarvio; Hospital de Cascais; Centro Hospitalar de Coimbra; Centro Hospitalar de Entre Douro e Vouga; Centro Hospitalar de Lisboa Central; Centro Hospitalar Lisboa Norte; Centro Hospitalar Lisboa Ocidental; Centro Hospitalar de Vila Nova de Gaia/Espinho; Centro Hospitalar do Alto Ave; Centro Hospitalar do Baixo Alentejo; Centro Hospitalar do Porto; Centro Hospitalar da Póvoa do Varzim/Vila do Conde; Hospital de Vila Real; Hospitais da Universidade de Coimbra; Hospital Central do Funchal; Hospital Curry Cabral, Lisboa; Hospital de Santa Luzia, Elvas; Hospital de Santo André, Leiria; Hospital de São João, Porto; Hospital de Braga; Hospital Dr. José Maria Grande, Portalegre; Hospital do Espírito Santo, Évora; Hospital dos SAMS, Lisboa; Hospital Dr. Fernando da Fonseca, Amadora/Sintra; Hospital Garcia de Orta, Almada; Hospital Infante D. Pedro, Aveiro; Hospital de São Teotónio,Viseu; Hospital Pedro Hispano, Matosinhos; Instituto Nacional de Saúde Ricardo Jorge, Porto; Hospital Reynaldo dos Santos, Vila Franca de Xira; Unidade Local de Saúde do Alto Minho; Hospital CUF Descobertas; Centro Hospitalar do Tâmega e Sousa; Hospital Beatriz Ângelo, Loures; Centro Hospitalar de Setúbal; Hospital Distrital de Santarém; Centro Hospitalar do Médio Ave; Hospital de Faro; Centro Hospitalar do Oeste Norte; Hospital da Luz; Hospital da Figueira da Foz.
Joana P LopesAuthor Affiliations: Centro Hospitalar do Barlavento Algarvio; Hospital de Cascais; Centro Hospitalar de Coimbra; Centro Hospitalar de Entre Douro e Vouga; Centro Hospitalar de Lisboa Central; Centro Hospitalar Lisboa Norte; Centro Hospitalar Lisboa Ocidental; Centro Hospitalar de Vila Nova de Gaia/Espinho; Centro Hospitalar do Alto Ave; Centro Hospitalar do Baixo Alentejo; Centro Hospitalar do Porto; Centro Hospitalar da Póvoa do Varzim/Vila do Conde; Hospital de Vila Real; Hospitais da Universidade de Coimbra; Hospital Central do Funchal; Hospital Curry Cabral, Lisboa; Hospital de Santa Luzia, Elvas; Hospital de Santo André, Leiria; Hospital de São João, Porto; Hospital de Braga; Hospital Dr. José Maria Grande, Portalegre; Hospital do Espírito Santo, Évora; Hospital dos SAMS, Lisboa; Hospital Dr. Fernando da Fonseca, Amadora/Sintra; Hospital Garcia de Orta, Almada; Hospital Infante D. Pedro, Aveiro; Hospital de São Teotónio,Viseu; Hospital Pedro Hispano, Matosinhos; Instituto Nacional de Saúde Ricardo Jorge, Porto; Hospital Reynaldo dos Santos, Vila Franca de Xira; Unidade Local de Saúde do Alto Minho; Hospital CUF Descobertas; Centro Hospitalar do Tâmega e Sousa; Hospital Beatriz Ângelo, Loures; Centro Hospitalar de Setúbal; Hospital Distrital de Santarém; Centro Hospitalar do Médio Ave; Hospital de Faro; Centro Hospitalar do Oeste Norte; Hospital da Luz; Hospital da Figueira da Foz.
Mário RamirezAuthor Affiliations: Centro Hospitalar do Barlavento Algarvio; Hospital de Cascais; Centro Hospitalar de Coimbra; Centro Hospitalar de Entre Douro e Vouga; Centro Hospitalar de Lisboa Central; Centro Hospitalar Lisboa Norte; Centro Hospitalar Lisboa Ocidental; Centro Hospitalar de Vila Nova de Gaia/Espinho; Centro Hospitalar do Alto Ave; Centro Hospitalar do Baixo Alentejo; Centro Hospitalar do Porto; Centro Hospitalar da Póvoa do Varzim/Vila do Conde; Hospital de Vila Real; Hospitais da Universidade de Coimbra; Hospital Central do Funchal; Hospital Curry Cabral, Lisboa; Hospital de Santa Luzia, Elvas; Hospital de Santo André, Leiria; Hospital de São João, Porto; Hospital de Braga; Hospital Dr. José Maria Grande, Portalegre; Hospital do Espírito Santo, Évora; Hospital dos SAMS, Lisboa; Hospital Dr. Fernando da Fonseca, Amadora/Sintra; Hospital Garcia de Orta, Almada; Hospital Infante D. Pedro, Aveiro; Hospital de São Teotónio,Viseu; Hospital Pedro Hispano, Matosinhos; Instituto Nacional de Saúde Ricardo Jorge, Porto; Hospital Reynaldo dos Santos, Vila Franca de Xira; Unidade Local de Saúde do Alto Minho; Hospital CUF Descobertas; Centro Hospitalar do Tâmega e Sousa; Hospital Beatriz Ângelo, Loures; Centro Hospitalar de Setúbal; Hospital Distrital de Santarém; Centro Hospitalar do Médio Ave; Hospital de Faro; Centro Hospitalar do Oeste Norte; Hospital da Luz; Hospital da Figueira da Foz.
José Melo-CristinoAuthor Affiliations: Centro Hospitalar do Barlavento Algarvio; Hospital de Cascais; Centro Hospitalar de Coimbra; Centro Hospitalar de Entre Douro e Vouga; Centro Hospitalar de Lisboa Central; Centro Hospitalar Lisboa Norte; Centro Hospitalar Lisboa Ocidental; Centro Hospitalar de Vila Nova de Gaia/Espinho; Centro Hospitalar do Alto Ave; Centro Hospitalar do Baixo Alentejo; Centro Hospitalar do Porto; Centro Hospitalar da Póvoa do Varzim/Vila do Conde; Hospital de Vila Real; Hospitais da Universidade de Coimbra; Hospital Central do Funchal; Hospital Curry Cabral, Lisboa; Hospital de Santa Luzia, Elvas; Hospital de Santo André, Leiria; Hospital de São João, Porto; Hospital de Braga; Hospital Dr. José Maria Grande, Portalegre; Hospital do Espírito Santo, Évora; Hospital dos SAMS, Lisboa; Hospital Dr. Fernando da Fonseca, Amadora/Sintra; Hospital Garcia de Orta, Almada; Hospital Infante D. Pedro, Aveiro; Hospital de São Teotónio,Viseu; Hospital Pedro Hispano, Matosinhos; Instituto Nacional de Saúde Ricardo Jorge, Porto; Hospital Reynaldo dos Santos, Vila Franca de Xira; Unidade Local de Saúde do Alto Minho; Hospital CUF Descobertas; Centro Hospitalar do Tâmega e Sousa; Hospital Beatriz Ângelo, Loures; Centro Hospitalar de Setúbal; Hospital Distrital de Santarém; Centro Hospitalar do Médio Ave; Hospital de Faro; Centro Hospitalar do Oeste Norte; Hospital da Luz; Hospital da Figueira da Foz.
Portuguese Group for the Study of Streptococcal Infections
Centro Hospitalar do Porto · PTUniversity of Lisbon · PTCentro Hospitalar de Lisboa Ocidental · PT
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since 2010 the 13-valent pneumococcal conjugate vaccine (PCV13) replaced the 7-valent vaccine (PCV7) as the leading pneumococcal vaccine used in children through the private sector. Although, neither of the PCVs were used significantly in adults, changes in adult invasive pneumococcal disease (IPD) were expected due to herd protection. We characterized
Indexed as
antimicrobial resistanceconjugate vaccinesinvasive diseasepolysaccharide vaccineserotypeStreptococcus pneumoniae
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.